QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer
Clinical trial NCT03127124 · WITHDRAWN
Trial details
- NCT number
- NCT03127124
- Sponsor
- NantPharma, LLC
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2023-12-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.